Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.265    -0.005 (-1.85%)
Bid:
0.25
Ask:
0.28
Spread: 0.03 (12.00%)
Market Cap: £15.36m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Directors' Subscription

29 Nov 2024 09:57

RNS Number : 1987O
CAP-XX Limited
29 November 2024
 

29 November 2024

CAP-XX Limited

("CAP-XX" or "the Company")

Directors' Subscription

Total voting rights

CAP-XX Limited (AIM:CPX), a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems, announces an update on the subscription for new ordinary shares in the Company by certain directors of the Company (the "Directors' Subscription"), details of which were set out in the announcement of the Company's recent fundraise on 31 October 2024 (the "Launch Announcement").

Following the publication of the annual report and accounts for the financial year ended 30 June 2024, Dr Graham Cooley and Peter Fraser (the "Participating Directors") have conditionally subscribed for a total of approximately £0.25m (before expenses) of new Ordinary Shares pursuant to the Directors' Subscription. The Directors' Subscription will result in the issue and allotment of a total of 227,272,700 new Ordinary Shares (the "Subscription Shares") and is being carried out at the same issue price of 0.11 pence and substantially identical terms as those of the Placing. Details of the number of Subscription Shares being subscribed for and the resultant holdings of the Participating Directors are set out below.

Director

Current holding of Ordinary Shares

Number ofSubscription Shares being subscribed for

Resultant holding of Ordinary Shares

Percentage of enlarged share capital* (%)

Dr Graham Cooley

355,000,000

218,181,800

573,181,800

9.98%

Peter Fraser

-

9,090,900

9,090,900

0.16%

Total

355,000,000

227,272,700

582,272,700

 

* the current issued share capital of 3,357,210,402 Ordinary Shares as enlarged by the 1,908,743,235 Second Placing Shares, the Subscription Shares and the 250,000,000 Retail Offer Shares.

The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation, is appended further below.

Related Party Transaction

Dr Graham Cooley is a substantial shareholder and director of the Company and Peter Fraser is a director of the Company. Therefore the Participating Directors are deemed to be related parties pursuant to the AIM Rules for Companies (the "AIM Rules").

The Directors' Subscription constitutes a related party transaction in accordance with Rule 13 of the AIM Rules. Accordingly, the independent Directors (being Patrick Elliot, Steen Feldskov, Dr Anthony Sive and Lars Stegmann) consider, having consulted with the Company's Nominated Adviser, Allenby Capital Limited, that the terms of the Directors' Subscription are fair and reasonable insofar as the Company's shareholders are concerned.

Application for admission to trading on AIM and total voting rights

Application has been made for the Subscription Shares to be admitted to trading on AIM and it is anticipated that this will take place at 8.00 a.m. on or around 9 December 2024, at the same time as the admission of the Second Placing Shares and the Retail Offer Shares ("Second Admission").

Following admission of the Subscription Shares and Second Admission, the Company's issued ordinary share capital will comprise 5,743,226,337 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Accordingly, the above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise defined, definitions contained in this announcement have the same meaning as set out in the Launch Announcement.

For further information contact:

CAP-XX Limited

Pat Elliott (Chairman) +61 (2) 9157 0000

Lars Stegmann (Chief Executive Officer)

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Piers Shimwell (Corporate Finance)  +44 (0) 20 3328 5656

Jos Pinnington/Tony Quirke (Sales and Corporate Broking)

 

Notes to Editors:

About CAP-XX

CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high-power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1) Dr Graham Cooley

2) Peter Fraser

2.

Reason for the Notification

a)

Position/status

1) Non-Executive Director

2) Non-Executive Director

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CAP-XX Limited

b)

LEI

213800HECUSIYXH3WN26

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of no par value each

Identification code

ISIN: AU0000XINAS1

b)

Nature of the transaction

Subscription for Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1) 0.11 pence per share

218,181,800

2) 0.11 pence per share

9,090,900

d)

Aggregated information:

-Aggregated volume

-Price

n/a

e)

Date of the transaction

29 November 2024 to be completed on 9 December 2024

f)

Place of the transaction

Outside of a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEKZMZMLLVGDZG
Date   Source Headline
23rd Apr 202110:21 amRNSAppointment of Joint Broker
30th Mar 20217:00 amRNSNotification of transactions by PDMRs
23rd Mar 20217:00 amRNSHolding(s) in Company
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
15th Mar 20217:00 amRNSPortal Instruments Selects CAP-XX Supercapacitors
25th Feb 20217:00 amRNSInterim Results
16th Feb 202112:55 pmRNSLight energy harvesting evaluation modules
9th Feb 20217:00 amRNSTrading update and notification of date of results
5th Jan 20219:06 amRNSHolding(s) in Company
4th Jan 20217:15 amRNSUpdate re Tax Rebate
31st Dec 202011:31 amRNSHolding(s) in Company
22nd Dec 202011:05 amRNSSecond Price Monitoring Extn
22nd Dec 202011:00 amRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSProduct shipped from new production lines
18th Dec 20207:00 amRNSHolding(s) in Company
10th Dec 20208:02 amRNSExercise of employee share options
30th Nov 20207:00 amRNSHolding(s) in Company
25th Nov 20208:15 amRNSResult of AGM and Chairman’s AGM statement
3rd Nov 202012:49 pmRNSReplacement: Audited results
3rd Nov 20207:00 amRNSAudited results for the year ended 30 June 2020
23rd Oct 20207:00 amRNSNotice of Results
8th Oct 20207:00 amRNSAward of LSE Green Economy Mark
10th Sep 20207:11 amRNSCorporate update
26th Aug 20208:23 amRNSHolding(s) in Company
25th Aug 202010:21 amRNSIssue of Shares
21st Aug 20204:41 pmRNSSecond Price Monitoring Extn
21st Aug 20204:36 pmRNSPrice Monitoring Extension
21st Aug 202011:05 amRNSSecond Price Monitoring Extn
21st Aug 202011:00 amRNSPrice Monitoring Extension
17th Aug 20207:35 amRNSHolding(s) in Company
7th Aug 20203:18 pmRNSIoxus intellectual property judgement
26th Jun 20207:28 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jun 20208:57 amRNSChange of Auditor
19th May 20207:00 amRNSTrading Update
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:01 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSInterim Results
4th Mar 20207:00 amRNSNotification of date of interim results and update
7th Jan 20207:00 amRNSHolding(s) in Company
6th Jan 20208:22 amRNSHolding(s) in Company
30th Dec 20198:30 amRNSResult of General Meeting
24th Dec 20197:00 amRNSResult of Offer to Qualifying Participants
29th Nov 20199:57 amRNSReplacement: Proposed Acquisition and Fundraising
29th Nov 20197:00 amRNSProposed Acquisition from Murata and Fundraising
28th Nov 20198:53 amRNSResult of AGM
13th Nov 20197:00 amRNSNotice of AGM
8th Nov 20197:00 amRNSAudited results for the year ended 30 June 2019
11th Sep 20197:00 amRNSHolding(s) in Company
31st Jul 20198:48 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.